University of Bern, Switzerland - Decrease in mortality from rare side effect [A large-scale international study co-led by Inselspital and the University of Bern]

Title:

Decrease in mortality from rare side effect

 

Published:

University of Bern, 28 September 2021

Click here to read

 

From the media release:

A large-scale international study co-led by Inselspital and the University of Bern investigated the very rare adverse cerebral venous occlusion (sinus venous thrombosis) after administration of the Oxford-AstraZeneca and Janssen/Johnson&Johnson vaccines. Neither vaccine has been used in Switzerland to date. The mortality rate due to this complication decreased from 61% to 42% after the mechanism of its onset was clarified in spring 2021.

 

University of Bern, Switzerland - AI improves speech understanding of hearing aid users

Title:

AI improves speech understanding of hearing aid users 

 

Published:

University of Bern, 30 June 2021

Click here to read

 

From the media release:

In noisy environments it is difficult for hearing aid users or people with a hearing implant to understand their conversational partner because current audio processors still have difficulty focusing precisely enough on specific sound sources. In a feasibility study, researchers from the Hearing Research Laboratory at the University of Bern and the Inselspital are now suggesting that artificial intelligence could solve this problem.